the swiss times
en_GB English
en_GB English de_DE German fr_FR French es_ES Spanish ar Arabic
the swiss times

Ypsomed Divests Pen Needle: Focuses on Insulin Pump Innovation

Ypsomed Divests Pen Needle: Focuses on Insulin Pump Innovation

Thu, Mar 28th 2024

Ypsomed transitions pen needle and BGM business to MTD, channeling investment into expanding Solothurn site and enhancing insulin pump solutions.

(KEYSTONE/Anthony Anex)

Ypsomed, a notable player in the healthcare sector, has divested its pen needle and glucose monitoring systems (BGMs) segment to Medical Technology and Devices S.p.A. (MTD) according to a press release.

This decision is aligned with Ypsomed’s vision to concentrate on advancing and commercialising its cutting-edge mylife Loop insulin pump solution. The transition to MTD, anticipated to finalise in summer 2024, is set to ensure a continuous supply of high-quality pen needles, catering to the global demand from insulin and hormone injectors.

In the interim, Ypsomed will continue manufacturing pen needles under a contract arrangement, facilitating a smooth transition by mid-2025. This business segment, now transitioning to MTD, recorded sales of over CHF 50 million in the fiscal year 2022/23, with a subsequent CHF 18 million in the first half of FY 2023/24.

MTD aims to enrich its portfolio with Ypsomed’s acclaimed click technology and its own 34G pen needle, envisioning expanded market reach and enhanced service to the diabetes community.

Ypsomed is set to channel over CHF 100 million into its Solothurn site over the next four years, boosting autoinjector production capabilities. This expansion will not only augment its manufacturing capacity but also introduce a new injection moulding tool shop, thereby creating numerous job opportunities.

Ypsomed assures its workforce of continued employment and is actively seeking avenues to accommodate all employees affected by the business transition within the group or through partner recruiting agencies.

Related Stories

UBS Makes Big Repayments To The SNB For Emergency Liquidity
Thumbnail

7 May 2024

UBS repays another CHF 9 billion in ELA to the Swiss National Bank, further reducing the emergency liquidity provided...

Credit Suisse CEO To Step Down As UBS Merger Accelerates
Thumbnail

6 May 2024

UBS plans to dissolve Credit Suisse's management in the coming weeks, with CEO Ulrich Körner leaving post-merger,...

Protests At ETH, Lausanne & Geneva: Students Take Direct Action
Thumbnail

7 May 2024

Protests advocating for Palestine surface at ETH Zurich, EPFL Lausanne, and the University of Geneva....

Swiss Firm, Montana Aerospace: 2024 Q1 Performance
Thumbnail

8 May 2024

Montana Aerospace AG reports a stellar Q1 2024 with solid financial growth and reconfirmed future guidance....

Cartier Luxury Watches Defy Market Downtrend
Thumbnail

8 May 2024

In a year where luxury watches have mostly seen a decline, Cartier stands out with a 2.4% increase in value on the...

Hochdorf: Shareholders To Change The Board
Thumbnail

3 May 2024

Hochdorf faces a significant board transformation as Newlat proposes six new candidates, predominantly Italian....

Switzerland To Pay The EU: ‘Cohesion Fund’
Thumbnail

6 May 2024

Switzerland enhances cooperation with the EU, committing to regular cohesion payments....

Stay in Touch

Noteworthy

Fedpol Director Nicoletta Valle To Step Down in 2025
Noteworthy
24 April 2024

Fedpol Director Nicoletta Valle To Step Down in 2025

Small Earthquake Recorded In Yvonand
Noteworthy
22 April 2024

Small Earthquake Recorded In Yvonand
the swiss times
A production of UltraSwiss AG, 6340 Baar, Switzerland

Quick Links

Home Privacy GTC Contact Us About Us
Copyright © 2024 UltraSwiss AG 2024 All rights reserved